17-Desacetyl norgestimate

CAS : 53016-31-2

Ref. 3D-FD21125

Informations sur le produit

• Nom: 17-Desacetyl norgestimate
• Synonymes: (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime17-Deacetylnorgestimate18-Methylnorethindrone oxime, (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one Oxime, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-(hydroxyimino)-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ol (non-preferred name), 17-Deacetylnorgestimate, 17-Deacylnorgestimate, 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, oxime, (17α)-, 18-Methylnorethindrone oxime, <span class="text-smallcaps">D</span>-Norgestrel 3-oxime, Brn 4202099, D-Norgestrel 3-oxime, Levonorgestrel 3-oxime, Levonorgestrel oxime, Norplant 3-oxime, Rwj 10553, d-(17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime
• CAS: 53016-31-2

Description

17-Desacetyl norgestimate is a contraceptive drug that is administered as a transdermal patch. It is used to prevent pregnancy by inhibiting ovulation and interfering with the production of progesterone, which is needed for the maintenance of pregnancy. Norgestimate binds to the progesterone receptor in the uterus and prevents implantation of a fertilized egg. 17-Desacetyl norgestimate has been shown to be effective in preventing pregnancies in women who are not using other hormonal contraceptives. This drug also has an anti-inflammatory effect on ovarian tissue, which may be due to its inhibition of pro-inflammatory cytokines such as IL-1β and TNFα.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 327.46 g/mol
• Formule: C₂₁H₂₉NO₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Off-White Solid
• InChI: InChI=1S/CH4/h1H4
• Code InChI: InChIKey=VNWKTOKETHGBQD-UHFFFAOYSA-N
• SMILES: C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C/C(=N/O)CC[C@@H]4[C@H]3CC[C@@]21CC